Avanos Medical (NYSE:AVNS) Upgraded at Wall Street Zen

Avanos Medical (NYSE:AVNS) was upgraded by equities researchers at Wall Street Zen from a “hold” rating to a “buy” rating in a research report issued on Saturday.

Several other research firms have also weighed in on AVNS. Zacks Research raised Avanos Medical from a “strong sell” rating to a “hold” rating in a research note on Monday, January 26th. Weiss Ratings restated a “sell (d-)” rating on shares of Avanos Medical in a research report on Monday, December 22nd. One analyst has rated the stock with a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat, the company presently has a consensus rating of “Reduce”.

Avanos Medical Price Performance

AVNS opened at $13.51 on Friday. The company has a fifty day moving average price of $13.82 and a two-hundred day moving average price of $12.36. The firm has a market capitalization of $628.30 million, a PE ratio of -8.55 and a beta of 1.07. Avanos Medical has a 52 week low of $9.30 and a 52 week high of $15.68. The company has a debt-to-equity ratio of 0.12, a quick ratio of 1.26 and a current ratio of 2.15.

Avanos Medical (NYSE:AVNS) last posted its quarterly earnings results on Tuesday, February 24th. The company reported $0.29 earnings per share for the quarter, beating analysts’ consensus estimates of $0.24 by $0.05. Avanos Medical had a positive return on equity of 5.47% and a negative net margin of 10.40%.The company had revenue of $180.90 million for the quarter, compared to the consensus estimate of $174.70 million. During the same quarter in the prior year, the business posted $0.43 EPS. The firm’s quarterly revenue was up .7% on a year-over-year basis. Avanos Medical has set its FY 2026 guidance at 0.900-1.100 EPS. As a group, analysts anticipate that Avanos Medical will post 1.32 earnings per share for the current year.

Institutional Trading of Avanos Medical

Large investors have recently made changes to their positions in the company. Northwestern Mutual Wealth Management Co. lifted its holdings in Avanos Medical by 1,596,514.5% during the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 14,896,413 shares of the company’s stock worth $167,287,000 after acquiring an additional 14,895,480 shares in the last quarter. Armistice Capital LLC raised its position in shares of Avanos Medical by 28.0% during the fourth quarter. Armistice Capital LLC now owns 3,200,000 shares of the company’s stock worth $35,936,000 after purchasing an additional 700,000 shares during the period. State Street Corp lifted its holdings in shares of Avanos Medical by 2.8% during the 4th quarter. State Street Corp now owns 1,954,785 shares of the company’s stock valued at $21,952,000 after purchasing an additional 53,523 shares in the last quarter. Geode Capital Management LLC lifted its holdings in shares of Avanos Medical by 1.6% during the 4th quarter. Geode Capital Management LLC now owns 1,084,504 shares of the company’s stock valued at $12,180,000 after purchasing an additional 16,980 shares in the last quarter. Finally, Charles Schwab Investment Management Inc. grew its position in shares of Avanos Medical by 20.5% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 1,040,666 shares of the company’s stock valued at $11,687,000 after purchasing an additional 176,716 shares during the period. Institutional investors own 95.17% of the company’s stock.

Avanos Medical Company Profile

Avanos Medical is a global medical technology company that develops and markets a broad portfolio of medical devices intended to improve patient outcomes in hospital, outpatient and post-acute care settings. The company’s products focus on three core therapy areas—pain management, enteral feeding and respiratory care—designed to help clinicians manage post-operative pain, deliver nutrition support and assist breathing for patients across a variety of acute and chronic conditions.

In its pain management segment, Avanos offers both non-opioid drug delivery systems and cryoanalgesia devices, including ambulatory infusion pumps and cooled radiofrequency ablation platforms.